炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 来源：财富投资网 摘要：脑机接口概念股持续上演涨停潮：连续两天涨停的个股家数高达20只。因此，投资参股脑机接口 企业的相关上市公司值得关注。 周二A股市场几大指数全面强势上扬，尤其是连续第13个交易日收阳线的上证指数再度创下十年来的新 高，市场整体的成交量在元旦节后呈现明显放大的趋势，表明A股市场经过了前一阶段的整固和蓄势， 在开年后已经进入了新的一轮健康稳步上升的周期中！从市场热点来看，周一已经进入全面大爆发阶段 的脑机接口概念在周二的市场人气热度继续发酵，创新医疗（002173）、岩山科技（002195）、三博脑 科（301293）、美好医疗（301363）、南京熊猫（600775）这几只脑机接口概念股已经连续两个交易日 股价封"一"字涨停板，其它在周二封"一"字板涨停的脑机接口概念股还包括普力特（002324）、国际医 学（000516）、塞力医疗（603716）、倍益康（920199）和嘉事堂（002462），另外还有翔宇医疗 （688626）、爱朋医疗（300753）、熵基科技（301330）、伟思医疗（688580）、谱尼测 ...

Core Insights - Brain-computer interface (BCI) technology enables direct communication between the brain and external devices, revolutionizing human-machine interaction and integrating advanced technologies such as neuroscience, AI, and new materials [2][4] - The global BCI industry is projected to reach $7.63 billion by 2029, indicating significant growth potential [4] - China and the United States are leading in BCI development, with a notable number of companies and products entering clinical stages [6][7] Industry Overview - The BCI industry is characterized by a competitive landscape with active companies in over 40 countries, primarily in the US and China, where the number of companies exceeds 100 [7] - As of early 2024, China holds 55.62% of the global patent technology in BCI, leading all countries [6] - The industry is still in its early stages, with many startups emerging and a significant increase in patent applications and funding events [55] Key Companies - **Qiangnao Technology**: Founded in 2018, it specializes in non-invasive BCI technology and has over 200 core patents, with a goal to help 1 million disabled individuals regain mobility [10][12] - **Brain Tiger Technology**: Established in 2021, it focuses on flexible invasive BCI technology and has made significant breakthroughs in core technologies [13][15] - **Brain Land Technology**: Founded in 2018, it integrates BCI technology with medical big data and AI, holding 147 patents as of April 2025 [20][21] - **Borecon**: Founded in 2021, it has developed high-performance BCI systems and has over 100 patents [24][25] - **Weiling Medical**: Established in 2019, it is focused on BCI technology and has initiated clinical research for implantable BCI systems [28] - **Roulint Technology**: Founded in 2020, it specializes in non-invasive BCI technology for consumer electronics and medical applications, holding 161 patents [33] - **Aipeng Medical**: Established in 2001, it has invested in BCI technology and developed several non-invasive BCI products [36][37] - **Kedou BCI**: Founded in 2016, it focuses on invasive BCI technology and has developed various microelectrodes and related devices [40][41] - **Sanbo Neuroscience**: Established in 2003, it has over 50 patents and is involved in clinical applications of BCI technology for neurological disorders [43] - **Chengyitong**: Founded in 2011, it has developed several non-invasive BCI prototypes and holds 303 patents, covering key areas of BCI technology [46] Technological Insights - BCI technology is categorized into invasive, semi-invasive, and non-invasive types, with a focus on improving accuracy, feedback speed, and safety [50][52] - The majority of BCI product development is currently centered on non-invasive devices due to their higher safety and market acceptance [53] - As of 2024, there are 222 registered medical devices related to BCI in China, with 194 classified as Class II medical devices [53]